• Conference Proceeding

A Q-TWiST analysis of lapatinib plus letrozole compared with letrozole alone as first-line therapy in hormone receptor positive (HR plus ) metastatic breast cancer (MBC)

Citation

Sherrill, B., Amonkar, M., Sherif, B., Maltzman, J., O'Rourke, L., & Johnston, S. (2009). A Q-TWiST analysis of lapatinib plus letrozole compared with letrozole alone as first-line therapy in hormone receptor positive (HR plus ) metastatic breast cancer (MBC). In [7], pp. 275–275. .

Abstract